Usage Information

Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy
Isabella T. Tai, … , David A. Owen, Lan Bo Chen
Isabella T. Tai, … , David A. Owen, Lan Bo Chen
Published June 1, 2005
Citation Information: J Clin Invest. 2005;115(6):1492-1502. https://doi.org/10.1172/JCI23002.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 15

Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy

Abstract

Overcoming resistance to chemotherapy and radiation therapy has been a difficult but important goal in the effort to cure cancer. We used gene-expression microarrays to identify differentially expressed genes involved in colorectal cancer resistance to chemotherapy and identified secreted protein, acidic and rich in cysteine (osteonectin) (SPARC) as a putative resistance-reversal gene by demonstrating low SPARC expression in refractory human MIP101 colon cancer cells. We were able to achieve restoration of their radiosensitivity and sensitivity to 5-fluorouracil and irinotecan by reexpression of SPARC in tumor xenografts. Moreover, treatment of mice with SPARC conferred increased sensitivity to chemotherapy and led to significant regression of xenografted tumors. The results show that modulation of SPARC expression affects colorectal cancer sensitivity to radiation and chemotherapy. SPARC-based gene or protein therapy may ameliorate the emergence of resistant clones and eradicate existing refractory clones and offers a novel approach to treating cancer.

Authors

Isabella T. Tai, Meiru Dai, David A. Owen, Lan Bo Chen

×

Usage data is cumulative from May 2024 through May 2025.

Usage JCI PMC
Text version 491 50
PDF 69 32
Figure 486 12
Table 46 0
Citation downloads 64 0
Totals 1,156 94
Total Views 1,250
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement